STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Sales, net	$ 38,266,211	$ 33,049,533	$ 43,596,926
Cost of sales:
Total cost of sales	38,219,165	34,077,709	34,489,115
Gross profit (loss)	47,046	(1,028,176)	9,107,811
Operating expenses:
Sales and marketing	6,819,825	5,848,164	5,706,483
Research and development	675,567	673,944	581,172
General and administrative	12,772,469	13,555,283	14,308,365
Impairment of assets	954,366
Total operating expenses	21,222,227	20,077,391	20,596,020
Loss from operations	(21,175,181)	(21,105,567)	(11,488,209)
Other income - TIA	5,951,516	5,900,985	6,223,891
Unrealized gain (loss) on debt and equity securities	(5,035,991)	10,806,320	(10,521,166)
Gain on trading debt and equity securities	5,626,262		5,574,792
Litigation proceeds	1,900,000
Interest and other income	547,361	1,000,428	1,446,661
Interest expense	(87,904)	(122,500)	(152,166)
Net loss before income taxes	(12,273,937)	(3,520,334)	(8,916,197)
Provision (benefit) for income taxes	291,293	8,366,190	(1,905,161)
Net loss	(12,565,230)	(11,886,524)	(7,011,036)
Preferred Stock dividend requirements	(230,444)	(230,444)	(231,946)
Net loss applicable to common shareholders	$ (12,795,674)	$ (12,116,968)	$ (7,242,982)
Basic loss per share	$ (0.43)	$ (0.4)	$ (0.24)
Diluted loss per share	$ (0.43)	$ (0.4)	$ (0.24)
Weighted average common shares outstanding:
Basic (in shares)	29,937,159	29,937,159	29,937,159
Diluted (in shares)	29,937,159	29,937,159	29,937,159
Cost of manufactured product
Cost of sales:
Total cost of sales	$ 35,106,047	$ 31,158,190	$ 30,894,985
Royalty expense to shareholder
Cost of sales:
Total cost of sales	$ 3,113,118	$ 2,919,519	$ 3,594,130